Call for Papers: Negative symptoms of schizophrenia
Submission Due Date: 31st September 2022
Rationale Negative symptoms are a core aspect of schizophrenia, seen in 50– 60% of patients and strongly related to impaired function. Despite their relevance, negative symptoms are often overshadowed by positive symptoms, and they remain poorly understood and an unmet need. In the last decade there has been a rebirth of interest in these symptoms, with new conceptual ideas, novel measurement tools, and how to conduct research. This is a good time to bring together perspectives on these issues, to facilitate progress in the treatment and better understanding of these problems.
Suggested scope and topics:
We would welcome papers that:
- Discuss clinical aspects of negative symptoms, their history and controversies, risk factors, phenomenology, and measurement
- Investigate the pathophysiology of negative symptoms: from the schizophrenia field, the influence of mood and cognitive symptoms, and the core neuroscience
- Examine negative symptoms from a transdiagnostic and transcultural perspective
- Discuss how we can treat and manage negative symptoms.
We now invite submissions from all authors describing original research and systematic reviews, along with analysis pieces. We welcome research that offers the potential of definitive evidence with strong methods, including robust external validation and/or large samples. To find out more, or to inform us of your intention to submit, please contact bjp@rcpsych.ac.uk
Why submit?
- Submissions handled and reviewed efficiently by experts in the field
- All papers in the theme issue will be free to view for a month
- All authors will have the option to publish their article online shortly after acceptance
- The theme issue is sent directly to 18,000 RCPsych members
- Research papers in the previous themed issue were downloaded an average of 1,651 times. The total number of downloads for all articles included in that issue is 27,485.
Guest Editors
Dr Emilio Fernandez-Egea, University of Cambridge, UK Professor Brian Kirkpatrick, University of Arkansas for Medical Sciences, USA Dr Jimmy Lee, Institute of Mental Health, Singapore Professor Armida Mucci, University of Campania, Italy